MedTrace Logo

Evaluation of a COVID-19 Rapid Diagnostic Test in ER Departments in Mexico: a Multi-center Study

NCT04894760 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 567

Last updated 2022-01-19

No results posted yet for this study

Summary

An observational (cross-sectional) study in the emergency services of participating hospitals, receiving patients with COVID-19 and influenza, aiming to evaluate the diagnostic performance of the rapid antigen detection test for COVID-19 both in nasal sampling and saliva, in patients attending emergency services in the 2020-2021 winter season, performed on site, compared to the gold standard (RT-qPCR).

Conditions

  • Covid19

Interventions

DIAGNOSTIC_TEST

Rapid Antigen Test (PanBio Ag test)

Rapid Antigen Test (PanBio Ag test)

Sponsors & Collaborators

  • National Institute of Respiratory Diseases, Mexico

    lead OTHER_GOV

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-12-30
Primary Completion
2021-06-30
Completion
2021-07-31
FDA Device
Yes

Countries

  • Mexico

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04894760 on ClinicalTrials.gov